Dexcom Stelo
Over-the-counter upper-arm glucose biosensor shows trends for adults not on insulin.
Keep in mind Do not use for problematic hypoglycemia. Medical decisions require consultation with a qualified professional.
Compare up to 10 devices across categories. Keep the purpose and the source beside the numbers.
Lowest recorded store prices take priority over announced or launch prices, within the selected source market. Currencies use the dated EUR reference rates. Deposits and recurring charges are excluded from price order; missing prices stay last. Original price records remain visible.
Over-the-counter upper-arm glucose biosensor shows trends for adults not on insulin.
Keep in mind Do not use for problematic hypoglycemia. Medical decisions require consultation with a qualified professional.
Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin.
Keep in mind FDA clearance is not proof of released sales. Lingo and Libre-family specifications are not substituted.
Published specifications and documented constraints. See the full comparison below for prices and sources.
Scroll across the table to compare every model
| Biosensors & healthAdd a model | ![]() | ![]() |
|---|---|---|
| Prices · all markets | $99 USD≈ €89 EURECB 2026-10-12US · Store price · Listed 1 offer records & sources$99 USD≈ €89 EURECB 2026-10-12 US · Store price ListedDexcom One-time purchase, two biosensors Official displayed price; shipping destination, tax treatment and checkout not tested.Check merchant offer ↗Price source ↗ Checked 2026-10-12 | Price not verified 0 offer records & sourcesNo verified price in this audit. |
| Designed for | Over-the-counter upper-arm glucose biosensor shows trends for adults not on insulin. ↗ | Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin. ↗ |
| Form factor | Upper-arm CGM biosensor ↗ | Continuous glucose biosensor ↗ |
| Measurement | Continuous interstitial glucose ↗ | Interstitial glucose monitoring ↗ |
| Wear Duration | Up to 15 days ↗ | Not verified |
| Intended Users | Adults 18+ not on insulin, without problematic hypoglycemia ↗ | Adults 18+ with type 2 diabetes, not using insulin ↗ |
| Interface | Stelo app for compatible smartphones ↗ | CGM system for glucose-pattern review ↗ |
| Vision correction | No prescription required in the US ↗ | Not applicable to this category |
| Purpose Class | OTC integrated continuous glucose monitor ↗ | Not applicable to this category |
| USRegulatory | Not applicable to this category | FDA OTC iCGM clearance announced June 2024 ↗ |
| Availability | Official product documentation checked. Country-specific fulfilment and checkout were not tested. | Official 2024 clearance announcement confirmed; no current exact Libre Rio retail launch or price verified. |
| Important context |
|
|
| Editorial pick & release | No editorial ranking recorded | No editorial ranking recorded |
| Evidence | Manufacturer source Checked 2026-10-12 | Manufacturer source Checked 2026-10-13 |
Battery claims use different conditions and are not a controlled benchmark. “Not verified” is an evidence gap, not a missing feature. Prices are dated regional snapshots. Deposits, bundles and historical launch prices are labelled. Brightness measurement methods and battery workloads vary by manufacturer.